普罗吉

导航

页面版权所有烟台普罗吉生物科技发展有限公司

鲁ICP备10034923号网站建设：中企动力烟台

普罗吉

MARKETING

市场营销

eHSP90α in front-line therapy in EGFR exon 19 deletion and 21 Leu858Arg mutations in advanced lung adenocarcinoma

2024/07/12 10:37

浏览量：

Expression of extracellular HSP90α in pre- and post-treatment samples of driver-gene-negative non-small cell lung cancer

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer